Effectiveness of an acellular synthetic matrix in the treatment of hard-to-heal leg ulcers

Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: Experimental and clinical evidence  ||FREE PAPER||

(2016) Marco Romanelli   Clinical Interventions in Aging

Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers: follow-up data

(2014) M. Romanelli et al.   Journal of Wound Care

A pre-clinical functional assessment of an acellular scaffold intended for the treatment of hard-to-heal wounds

(2013) Gary K Shooter et al.   International Wound Journal

Chronic venous leg ulcers: the future of cell-based therapies

(2012) Matthias Augustin et al.   LANCET

Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial

(2012) Robert S Kirsner et al.   LANCET

Analysis of Matrix-Dependent Cell Migration with a Barrier Migration Assay

(2010) S. Kroening et al.   Science Signaling

Human skin wounds: A major and snowballing threat to public health and the economy

(2009) Chandan K. Sen et al.   WOUND REPAIR AND REGENERATION